Antigen-specific cytokine and antibody isotype profiles induced by mucosal and systemic immunization with recombinant adenoviruses

被引:6
作者
Papp, Z [1 ]
Babiuk, LA [1 ]
Baca-Estrada, ME [1 ]
机构
[1] Univ Saskatchewan, Vet Infect Dis Org, Saskatoon, SK S7N 5E3, Canada
关键词
D O I
10.1089/vim.1999.12.107
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated antigen-specific antibody and T-cell responses in mice immunized with human adenovirus type 5 (HAd5) vectors expressing either the authentic or truncated form of glycoprotein D (gD and tgD, respectively) of bovine herpesvirus type 1 (BHV-1). We also tested whether different routes of immunization influenced the level and type of immunity, Immunization intranasally (i.n.) stimulated higher levels of gD-specific IgA in the lung and nasal washes and induced a higher frequency of gD-specific antibody secreting cells (CSs) in the lung than did immunization subcutaneously (s.c.). In addition, immunization i.n. stimulated go-specific systemic antibody responses of a higher IgG1/IgG2a ratio and lower numbers of gD-specific interferon (IFN)-gamma SCs in the spleen than did immunization s.c. HAd5-specific responses also depended on the route of immunization and were characterized by lower IFN-gamma interleukin (IL)-4 ratios than go-specific responses. Immunization with the tgD-expressing vector induced generally lower antibody and cytokine responses than the gD-expressing vector, sigher numbers of antigen-specific IgA SCs in the lung as measured by enzyme-linked immunospot (ELISPOT) assay correlated with higher levels of IgA in the respiratory tract as measured by enzyme-linked immunosorbent (ELISA) assay, although there was no such correlation for IgG responses of any isotype. In conclusion, the route of immunization and form of antigen had an impact on the level and type of immune responses induced by adenovirus vectors.
引用
收藏
页码:107 / 116
页数:10
相关论文
共 25 条
[11]   Comparison of the efficacy of replication defective adenovirus and Nyvac poxvirus as vaccine vectors in mice [J].
Gonin, P ;
Oualikene, W ;
Fournier, A ;
Eloit, M .
VACCINE, 1996, 14 (11) :1083-1087
[12]  
Graham F L, 1991, Methods Mol Biol, V7, P109, DOI 10.1385/0-89603-178-0:109
[13]   ADENOVIRUS VECTORS AS RECOMBINANT VIRAL VACCINES [J].
IMLER, JL .
VACCINE, 1995, 13 (13) :1143-1151
[14]   HEAT-SHOCK PROMOTER-DRIVEN SYNTHESIS OF SECRETED BOVINE HERPESVIRUS GLYCOPROTEINS IN TRANSFECTED CELLS [J].
KOWALSKI, J ;
GILBERT, SA ;
VANDRUNENLITTELVANDENHURK, S ;
VANDENHURK, J ;
BABIUK, LA ;
ZAMB, TJ .
VACCINE, 1993, 11 (11) :1100-1107
[15]   Protective immunity in cattle following vaccination with conventional and marker bovine herpesvirus-1 (BHV1) vaccines [J].
LittelvandenHurk, SV ;
Tikoo, SK ;
vandenHurk, JV ;
Babiuk, LA ;
VanDonkersgoed, J .
VACCINE, 1997, 15 (01) :36-44
[16]   Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD [J].
Mittal, SK ;
Papp, Z ;
Tikoo, SK ;
BacaEstrada, ME ;
Yoo, D ;
Benko, M ;
Babiuk, LA .
VIROLOGY, 1996, 222 (02) :299-309
[17]   The effect of pre-existing adenovirus-specific immunity on immune responses induced by recombinant adenovirus expressing glycoprotein D of bovine herpesvirus type 1 [J].
Papp, Z ;
Babiuk, LA ;
Baca-Estrada, ME .
VACCINE, 1999, 17 (7-8) :933-943
[18]   Induction of immunity in the respiratory tract and protection from bovine herpesvirus type I infection by different routes of immunization with recombinant adenovirus [J].
Papp, Z ;
Babiuk, LA ;
Baca-Estrada, ME .
VIRAL IMMUNOLOGY, 1998, 11 (02) :79-91
[19]   USE OF HUMAN ADENOVIRUS-BASED VECTORS FOR ANTIGEN EXPRESSION IN ANIMALS [J].
PREVEC, L ;
SCHNEIDER, M ;
ROSENTHAL, KL ;
BELBECK, LW ;
DERBYSHIRE, JB ;
GRAHAM, FL .
JOURNAL OF GENERAL VIROLOGY, 1989, 70 :429-434
[20]  
Rosenthal Kenneth L., 1996, P147, DOI 10.1016/B978-012410580-5/50012-1